Syndax Pharmaceuticals Stock Target Price and Analyst Consensus
| SNDX Stock | USD 19.71 0.18 0.90% |
The current analyst and expert consensus on Syndax Pharmaceuticals is Strong Buy, with 8 strong buy opinions. The current projected Syndax Pharmaceuticals target price consensus is 36.09 with 13 analyst opinions. The most common way Syndax Pharmaceuticals analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Syndax Pharmaceuticals executives and customers to further validate their buy or sell advice. Syndax Pharmaceuticals buy-or-sell recommendation module provides average expert sentiment on the projected Syndax Pharmaceuticals target price to derive its highest and lowest estimates based on its projected price volatility. Check out Macroaxis Advice on Syndax Pharmaceuticals to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For more information on how to buy Syndax Stock please use our How to Invest in Syndax Pharmaceuticals guide.
Lowest Forecast 32.84 | Highest Forecast 40.06 | Target Price 36.09 |
Syndax |
It's important to approach Syndax Pharmaceuticals' target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Syndax Pharmaceuticals Target Price Consensus
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Syndax target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Syndax Pharmaceuticals' target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 13 | Strong Buy |
Most Syndax analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Syndax stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Syndax Pharmaceuticals, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationSyndax Pharmaceuticals Target Price Projection
Syndax Pharmaceuticals' current and average target prices are 19.71 and 36.09, respectively. The current price of Syndax Pharmaceuticals is the price at which Syndax Pharmaceuticals is currently trading. On the other hand, Syndax Pharmaceuticals' target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Current Price
Syndax Pharmaceuticals Market Quote on 20th of October 2024
Target Price
Analyst Consensus On Syndax Pharmaceuticals Target Price
Syndax Pharmaceuticals Analyst Ratings
Syndax Pharmaceuticals' analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Syndax Pharmaceuticals stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Syndax Pharmaceuticals' financials, market performance, and future outlook by experienced professionals. Syndax Pharmaceuticals' historical ratings below, therefore, can serve as a valuable tool for investors.Analyst Consensus Breakdown
Average Consensus Estimates
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Syndax Pharmaceuticals price targets
Syndax Pharmaceuticals' stock target price is an estimate of its future price, usually made by analysts. Using Syndax Pharmaceuticals' target price to determine if it is a suitable investment can be done through the following steps:- Look at Syndax Pharmaceuticals' target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Syndax Pharmaceuticals' stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Syndax Pharmaceuticals Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Syndax Pharmaceuticals is a key component of Syndax Pharmaceuticals valuation and have some predictive power on the future returns of a Syndax Pharmaceuticals.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Syndax Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Corona Opportunity Invested few shares | |
 | Power Assets Invested over 200 shares | |
 | Artificial Intelligence Invested few shares | |
 | Momentum Invested over 60 shares | |
 | Business Services Invested few shares | |
 | Banking Invested over 20 shares | |
 | Investor Favorites Invested few shares | |
 | Macroaxis Index Invested over 90 shares | |
Additional Tools for Syndax Stock Analysis
When running Syndax Pharmaceuticals' price analysis, check to measure Syndax Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Syndax Pharmaceuticals is operating at the current time. Most of Syndax Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Syndax Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Syndax Pharmaceuticals' price. Additionally, you may evaluate how the addition of Syndax Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.